Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)

NCT00256854 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Restless Legs Syndrome
Restless Legs Syndrome (RLS)

Interventions

DRUG: Ropinirole IR 1 mg
DRUG: Ropinirole IR 2 mg
DRUG: Ropinirole IR 1 mg Placebo
DRUG: Ropinirole IR 2 mg Placebo
DRUG: Ropinirole CR 2 mg
DRUG: Ropinirole CR 3 mg
DRUG: Ropinirole CR 2 mg Placebo
DRUG: Ropinirole CR 3 mg Placebo

Sponsor

GlaxoSmithKline